Complete nucleotide and deduced amino acid sequence of human beta 2-glycoprotein I.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Biochemical Journal

• Publication date

  1991-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1042/BJ2770387PMID 1650181PMCID PMC1151245
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human complement factor H: two factor H proteins are derived from alternatively spliced transcripts

  1991cited by this paper
• Secondary structure of a complement control protein module by two-dimensional 1H NMR.

  1991cited by this paper
• Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).

  1990cited by this paper
• Effect of the carbohydrate moiety on the secondary structure of beta 2-glycoprotein. I. Implications for the biosynthesis and folding of glycoproteins.

  1990cited by this paper
• Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor.

  1990cited by this paper
• Structure-function relationships of the complement components.

  1989cited by this paper
• The primary structure of rat beta 2-glycoprotein I.

  1989cited by this paper
• Disulfide bonds are localized within the short consensus repeat units of complement regulatory proteins: C4b-binding protein.

  1989cited by this paper
• Blood.

  1989cited by this paper
• A strategy for the rapid multiple alignment of protein sequences. Confidence levels from tertiary structure comparisons.

  1987cited by this paper
• Beta 2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation.

  1987cited by this paper
• Detecting homology of distantly related proteins with consensus sequences.

  1987cited by this paper
• Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I.

  1986cited by this paper
• beta 2-Glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway.

  1985cited by this paper
• Synthetic oligonucleotide probes deduced from amino acid sequence data. Theoretical and practical considerations.

  1985cited by this paper
• Genomic sequencing.

  1984cited by this paper
• Complete amino acid sequence of human plasma beta 2-glycoprotein I.

  1984cited by this paper
• beta 2-Glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles.

  1984cited by this paper
• Establishing homologies in protein sequences.

  1983cited by this paper
• A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

  1983cited by this paper
• Investigations on beta 2-glycoprotein-I in the rat: isolation from serum and demonstration in lipoprotein density fractions.

  1980cited by this paper
• Binding of beta 2-glycoprotein I to platelets: effect of adenylate cyclase activity.

  1980cited by this paper
• The binding of beta 2-glycoprotein-I to human serum lipoproteins: distribution among density fractions.

  1979cited by this paper
• Purification, characterization and identification of an agglutinin in human serum.

  1979cited by this paper
• DNA-binding proteins in Yoshida ascites tumor fluid.

  1976cited by this paper

• Comprehensive Review of Antiphospholipid Syndrome: Over Four Decades of Advances and Challenges.

  2026cites this paper
• Evolution of Antiphospholipid Syndrome

  2023cites this paper
• Carbamylation of β2-GPI generates new autoantigens for Antiphospholipid Syndrome: a new tool for diagnosis of "seronegative" patients.

  2022cites this paper
• Studies of the cardiolipin interactome.

  2022cites this paper
• The complement system and human autoimmune diseases.

  2022cites this paper
• Effects of anti‐beta 2‐glycoprotein 1 antibodies and its association with pregnancy‐related morbidity in antiphospholipid syndrome

  2021cites this paper
• A Personal Tribute to Robert B. Sim with Reflections on Our Work Together on Factor H

  2021cites this paper
• A Tribute to Robert (Bob) Sim—Personal Memories of Working in Bob’s Lab

  2021cites this paper
• Antiphospholipid antibodies and extracellular vesicles in pregnancy

  2020cites this paper
• A glimpse into the history of description of the antiphospholipid syndrome

  2020cites this paper
• Endothelium structure and function in kidney health and disease

  2019cites this paper
• Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL)

  2019cites this paper
• Interleukin-17/Interleukin-21 and Interferon-γ producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome

  2019cites this paper
• Simultaneous characterization of SNPs and N-glycans from multiple glycosylation sites of intact β-2-glycoprotein-1 (B2GP1) by ESI-qTOF-MS.

  2019cites this paper
• Post-translational modifications of proteins in antiphospholipid antibody syndrome

  2019cites this paper
• New insight into antiphospholipid syndrome: antibodies to β2glycoprotein I-domain 5 fail to induce thrombi in rats

  2018cites this paper
• Mutants of β2-glycoprotein I: Their features and potent applications.

  2018cites this paper
• Plasmodium berghei EXP-1 interacts with host Apolipoprotein H during Plasmodium liver-stage development

  2017cites this paper
• Potential influences of complement factor H in autoimmune inflammatory and thrombotic disorders

  2017cites this paper
• Recent Advances in Understanding of the Genetics of Antiphospholipid Syndrome

  2017cites this paper
• β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome

  2017cites this paper
• Antiphospholipid Syndrome

  2017influential citation
• 15th International Congress on Antiphospholipid Antibodies Task Force on Antiphospholipid Syndrome Treatment Trends Report

  2017cites this paper
• β2GP1, Anti-β2GP1 Antibodies and Platelets: Key Players in the Antiphospholipid Syndrome

  2016cites this paper
• Detection of circulating immune complexes of human IgA and beta 2 glycoprotein I in patients with antiphospholipid syndrome symptomatology.

  2015cites this paper
• Antiphospholipid syndrome: 30 years and our contribution

  2015cites this paper
• A potential anti-coagulant role of complement factor H.

  2014cites this paper
• Beta-2 glycoprotein1: function in health and disease

  2014influential citation
• Digital Image Processing Assessment of the Differential in vitro Antiangiogenic Effects of Dimeric and Monomeric Beta2-Glycoprotein I

  2013cites this paper
• Domain V Into a Nicked Form 2Glycoprotein I by Cleaving β Plasmin Can Reduce the Function of Human

  2013cites this paper
• β2-Glycoprotein I – A Protein in Search of Function

  2012cites this paper
• What is the genetics of antiphospholipid antibodies/syndrome?

  2012cites this paper
• Revisiting beta 2 glycoprotein I, the major autoantigen in the antiphospholipid syndrome.

  2012cites this paper
• Apolipoprotein H, an Acute Phase Protein, a Performing Tool for Ultra-Sensitive Detection and Isolation of Microorganisms from Different Origins

  2011influential citation
• β₂-Glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model.

  2011cites this paper
• Antiphospholipid Syndrome: Pathogenesis

  2011cites this paper
• Laboratory Testing for Antiphospholipid Syndrome

  2011cites this paper
• Characterization of sialylated and fucosylated glycopeptides of beta2-glycoprotein I by a combination of HILIC LC and MALDI MS/MS.

  2010cites this paper
• A β2-glicoproteína I no contexto da resposta inflamatória de fase aguda

  2010cites this paper
• β2‐Glycoprotein I‐derived peptides as antigenic structures for the detection of antiphospholipid antibodies

  2010cites this paper
• Affinity Capillary Electrophoresis of β 2-glycoprotein I and Anionic Phospholipids Analytical chemistry Diploma work

  2010cites this paper
• FUNCTIONAL CHARACTERIZATION OF APOLIPOPROTEIN H POLYMORPHISMS AND THEIR RELATION TO SYSTEMIC LUPUS ERYTHEMATOSUS

  2009cites this paper
• Glycopeptide profiling of beta-2-glycoprotein I by mass spectrometry reveals attenuated sialylation in patients with antiphospholipid syndrome.

  2009cites this paper
• Chapter 8 Interactions of Phospholipid Binding Proteins with Negatively Charged Membranes: β2‐Glycoprotein I as a Model Mechanism

  2008cites this paper
• Recombinant hepatitis B surface antigen and anionic phospholipids share a binding region in the fifth domain of beta2-glycoprotein I (apolipoprotein H).

  2008cites this paper
• Annexin A2: biology and relevance to the antiphospholipid syndrome

  2008cites this paper
• Staphylococcus aureus expresses a cel I surface protein that binds both IgG and P ,-glycoprotein

  2008cites this paper
• Plasmin-Cleaved β-2-Glycoprotein 1 Is an Inhibitor of Angiogenesis

  2007cites this paper
• Interaction of beta2-glycoprotein 1 with phosphatidylserine-containing membranes: ligand-dependent conformational alterations initiate bivalent binding.

  2007cites this paper
• Plasmin-cleaved beta-2-glycoprotein 1 is an inhibitor of angiogenesis.

  2007cites this paper
• Beta2-glycoprotein I and its clinical significance: from gene sequence to protein levels.

  2007cites this paper
• Some recent insights into the prothrombogenic mechanisms of antiphospholipid antibodies.

  2007cites this paper
• Investigating the molecular targets of antiphospholipid antibodies

  2007influential citation
• Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human beta(2)-glycoprotein I: mutation studies including residues R39 to R43.

  2007cites this paper
• RT-PCR and in situ hybridization analysis of apolipoprotein H expression in rat normal tissues.

  2006cites this paper
• Plasma Protein β-2-Glycoprotein 1 Mediates Interaction between the Anti-tumor Monoclonal Antibody 3G4 and Anionic Phospholipids on Endothelial Cells*

  2006cites this paper
• A novel expression system of domain I of human beta2 glycoprotein I in Escherichia coli

  2006cites this paper
• Towards bacterial strains overproducing l-tryptophan and other aromatics by metabolic engineering

  2006cites this paper
• Biotinylation of glycan chains in beta2 glycoprotein I induces dimerization of the molecule and its detection by the human autoimmune anti-cardiolipin antibody EY2C9.

  2006cites this paper
• A peptide that mimics the Vth region of β2glycoprotein I reverses antiphospholipid-mediated thrombosis in mice

  2006cites this paper
• Antigenic structures recognized by anti-beta2-glycoprotein I auto-antibodies.

  2005cites this paper
• IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis.

  2005cites this paper
• Recruitment of beta-2-glycoprotein 1 to cell surfaces in extrinsic and intrinsic apoptosis

  2005cites this paper
• Oxidation and biotinylation of beta 2 glycoprotein I glycan chains induce an increase in its affinity for anionic phospholipids similar to that obtained by the addition of anti-beta 2 glycoprotein I or anti-cardiolipin antibodies.

  2005cites this paper
• Budding, vesiculation and permeabilization of phospholipid membranes-evidence for a feasible physiologic role of beta2-glycoprotein I and pathogenic actions of anti-beta2-glycoprotein I antibodies.

  2005cites this paper
• Beta-2-glycoprotein specificity of human anti-phospholipid antibody resides on the light chain: a novel mechanism for acquisition of cross-reactivity by an autoantibody.

  2005cites this paper
• Antiphospholipid syndrome: characteristics and obstetrical management.

  2005cites this paper
• Domain V of β2-Glycoprotein I Binds Factor XI/XIa and Is Cleaved at Lys317-Thr318*

  2005cites this paper
• Beta-2 glycoprotein I and its role in antiphospholipid syndrome-lessons from knockout mice.

  2004cites this paper
• Beta 2 glycoprotein I--function in health and disease.

  2004influential citation
• Pathophysiology of antiphospholipid antibodies.

  2004influential citation
• The effect of phospholipids on the formation of immune complexes between autoantibodies and beta2-glycoprotein I or prothrombin.

  2004cites this paper
• Cloning and characterization of the human beta2-glycoprotein I (beta2-GPI) gene promoter: roles of the atypical TATA box and hepatic nuclear factor-1alpha in regulating beta2-GPI promoter activity.

  2004cites this paper
• Beta 2-Glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: loss of inhibition by clipped beta 2-glycoprotein I.

  2004cites this paper
• A peptide that shares similarity with bacterial antigens reverses thrombogenic properties of antiphospholipid antibodies in vivo.

  2004cites this paper
• Sorting a Staphylococcus aureus phage display library against ex vivo biomaterial.

  2004cites this paper
• Immunology of anti-phospholipid antibodies and cofactors

  2004cites this paper
• A systematic analysis of sequences of human antiphospholipid and anti-beta2-glycoprotein I antibodies: the importance of somatic mutations and certain sequence motifs.

  2003cites this paper
• Prevalence and Clinical Correlations of Antibodies Against Six β2-Glycoprotein-I-Related Peptides in the Antiphospholipid Syndrome

  2003cites this paper
• How do antiphospholipid antibodies bind β2-glycoprotein I?

  2003cites this paper
• Lack of association of b 2-glycoprotein I polymorphisms Val247Leu and Trp316Ser with antiphospholipid antibodies in patients with thrombosis and pregnancy complications

  2003cites this paper
• Anti-cardiolipin/beta-2 glycoprotein activities co-exist on human anti-DNA antibody light chains.

  2003cites this paper
• Beta‐2‐glycoprotein I expression on monocytes is increased in anti‐phospholipid antibody syndrome and correlates with tissue factor expression

  2003cites this paper
• A functional polymorphism at the transcriptional initiation site in beta2-glycoprotein I (apolipoprotein H) associated with reduced gene expression and lower plasma levels of beta2-glycoprotein I.

  2003cites this paper
• How do antiphospholipid antibodies bind beta2-glycoprotein I?

  2003cites this paper
• Studies on specific interaction of beta-2-glycoprotein I with HBsAg.

  2003cites this paper
• Lack of association of β2‐glycoprotein I polymorphisms Val247Leu and Trp316Ser with antiphospholipid antibodies in patients with thrombosis and pregnancy complications

  2003cites this paper
• [Antigenic structures recognized by anti-beta 2-glycoprotein I autoantibodies].

  2003cites this paper
• Regular Article Polymorphisms h2-glycoprotein I: phospholipid binding and multimeric structure

  2003cites this paper
• Anti-β2-glycoprotein I antibodies and the antiphospholipid syndrome

  2003cites this paper
• Anti-beta(2)-glycoprotein I antibodies and the antiphospholipid syndrome.

  2003cites this paper
• Prevalence and clinical correlations of antibodies against six beta2-glycoprotein-I-related peptides in the antiphospholipid syndrome.

  2003cites this paper
• Polymorphisms beta2-glycoprotein I: phospholipid binding and multimeric structure.

  2002cites this paper
• Human &-Glycoprotein I as an Anticardiolipin Cofactor Determined Using Deleted Mutants Expressed by a Baculovirus System

  2002cites this paper
• Anti‐β2‐glycoprotein I antibodies in children with atopic dermatitis

  2002cites this paper
• Solution structure of human and bovine beta(2)-glycoprotein I revealed by small-angle X-ray scattering.

  2002cites this paper
• β2-glycoprotein-I and Anti-β2-glycoprotein-I Antibodies1

  2002cites this paper
• Anti-β2-glycoprotein I Antibody-mediated Inhibition of Activated Protein C Requires Binding of β2-glycoprotein I to Phospholipids

  2002cites this paper
• Polimorfismo de la β2-glucoproteína I. Relevancia en el síndrome de antifosfolípidos

  2002cites this paper
• Anti-beta(2)-glycoprotein I antibody-mediated inhibition of activated protein C requires binding of beta(2)-glycoprotein I to phospholipids.

  2002cites this paper